-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
NeuBase Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q4 2011 to Q3 2023.
- NeuBase Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 2.76M shares, a 70.8% increase year-over-year.
- NeuBase Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 32.5M shares, a 19% increase from 2021.
- NeuBase Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 27.3M shares, a 39.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)